CEFAZOLIN SODIUM FOR INJECTION BP POWDER FOR SOLUTION

국가: 캐나다

언어: 영어

출처: Health Canada

유효 성분:

CEFAZOLIN (CEFAZOLIN SODIUM)

제공처:

STERIMAX INC

ATC 코드:

J01DB04

INN (국제 이름):

CEFAZOLIN

복용량:

1G

약제 형태:

POWDER FOR SOLUTION

구성:

CEFAZOLIN (CEFAZOLIN SODIUM) 1G

관리 경로:

INTRAMUSCULAR

패키지 단위:

15G/50G

처방전 유형:

Prescription

치료 영역:

FIRST GENERATION CEPHALOSPORINS

제품 요약:

Active ingredient group (AIG) number: 0109442005; AHFS:

승인 상태:

APPROVED

승인 날짜:

2022-02-11

제품 특성 요약

PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
CEFAZOLIN SODIUM FOR INJECTION BP
Powder for Solution, 1 gram, 2 grams and 10 grams Cefazolin (as
cefazolin sodium) per vial
Intravenous, Intramuscular
BP
Antibiotic
SteriMax Inc.
Date of Initial Authorization: JUN 24, 2020
2770 Portland Drive
Oakville, ON
Date of Revision: SEP 14, 2022
L6H 6R4
Control No: 263261
Pr
CEFAZOLIN SODIUM FOR INJECTION BP Page 2 of 21
RECENT MAJOR LABEL CHANGES
7 WARNINGS AND PRECAUTIONS, SKIN
01/2021
7 WARNINGS AND PRECAUTIONS, RENAL
09/2022
TABLE OF CONTENTS
Sections or subsections that are not applicable at the time of
authorization are not listed.
RECENT MAJOR LABEL CHANGES
...............................................................................................
2
TABLE OF CONTENTS
.................................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................................
4
1
INDICATIONS
......................................................................................................................
4
1.1
Pediatrics
..............................................................................................................................
5
1.2
Geriatrics
..............................................................................................................................
5
2
CONTRAINDICATIONS
.........................................................................................................
5
4
DOSAGE AND ADMINISTRATION
.........................................................................................
5
4.2
Recommended Dose and Dosage Adjustment
.................................................................... 5
4.3
Reconstitution
......................................................................................................................
7
4.4
Administration
.................................................................................